|Rakuten Ventures||Japan, Setagaya|
|Nordic Bioscience||Denmark, Herlev|
|ACRE Capital LLC||United States, Texas|
|Rastar Capital||China, Guangzhou|
|Shuimu Fund - Investments, Portfolio & Company Exits||-|
|365 Retail Markets||United States, Troy|
|Converge Ventures||United States, Hilliard|
|TIW Private Equity||-|
|Kajima Corp||Japan, Tateyama|
|Yarui Baichang Touzi||-|
|Arpwood Investment Advisors||-|
|HealthInvest Equity Partners||United States, Stamford|
|Tourne View Ventures||United States, New York|
|Roser Ventures||United States, Boulder|
|Upstream Ventures||Russia, Moscow|
|Weiran Capital||China, Shanghai|
|ASICS Ventures Corporation||Japan, Kyotango|
|UOB Venture||Singapore, Singapore|
|25 Jan 2021||France, " France"}|
|$1M||18 Dec 2019||China, Haidian District|
|20 Mar 2019||China, Haidian District|
|21 Feb 2019||China, Dongcheng District|
|$2M||14 Nov 2018||China, Shanghai|
|$3M||12 Nov 2018||China, Qingyang District|
|$24M||06 Mar 2018||China, Shanghai|
|$9M||31 Jan 2018||China, Shanghai|
|08 May 2017||China, Dongcheng District|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.